Rank | Gene Set | Z-score |
---|---|---|
1 | protein neddylation (GO:0045116) | 6.53538261 |
2 | neutrophil activation involved in immune response (GO:0002283) | 6.09906946 |
3 | thrombin receptor signaling pathway (GO:0070493) | 5.79205361 |
4 | leukocyte migration involved in inflammatory response (GO:0002523) | 5.41219086 |
5 | presynaptic membrane organization (GO:0097090) | 5.23755206 |
6 | presynaptic membrane assembly (GO:0097105) | 4.97293312 |
7 | facial nerve structural organization (GO:0021612) | 4.67933967 |
8 | regulation of platelet aggregation (GO:0090330) | 4.57175794 |
9 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.54689396 |
10 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.44077229 |
11 | neutrophil activation (GO:0042119) | 4.29646907 |
12 | postsynaptic membrane organization (GO:0001941) | 4.24363108 |
13 | regulation of MHC class II biosynthetic process (GO:0045346) | 4.23613757 |
14 | regulation of platelet activation (GO:0010543) | 4.23413843 |
15 | positive regulation of granulocyte differentiation (GO:0030854) | 4.10619882 |
16 | low-density lipoprotein particle remodeling (GO:0034374) | 4.10037803 |
17 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.96014788 |
18 | neuronal action potential propagation (GO:0019227) | 3.93251433 |
19 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.92246413 |
20 | neuromuscular process controlling posture (GO:0050884) | 3.84984895 |
21 | high-density lipoprotein particle remodeling (GO:0034375) | 3.81662579 |
22 | blood coagulation, intrinsic pathway (GO:0007597) | 3.77616632 |
23 | phospholipid homeostasis (GO:0055091) | 3.76828407 |
24 | vocalization behavior (GO:0071625) | 3.74140715 |
25 | respiratory chain complex IV assembly (GO:0008535) | 3.73827083 |
26 | negative regulation of thymocyte apoptotic process (GO:0070244) | 3.73672501 |
27 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.72693320 |
28 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.72693320 |
29 | positive regulation of mast cell activation (GO:0033005) | 3.71021745 |
30 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.70198944 |
31 | succinate metabolic process (GO:0006105) | 3.67851185 |
32 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.65858217 |
33 | granulocyte activation (GO:0036230) | 3.56219173 |
34 | cranial nerve structural organization (GO:0021604) | 3.55615075 |
35 | leukocyte degranulation (GO:0043299) | 3.55553257 |
36 | regulation of memory T cell differentiation (GO:0043380) | 3.53229198 |
37 | opioid receptor signaling pathway (GO:0038003) | 3.51064241 |
38 | peptidyl-threonine dephosphorylation (GO:0035970) | 3.50717737 |
39 | negative regulation of platelet activation (GO:0010544) | 3.50629917 |
40 | autophagic vacuole fusion (GO:0000046) | 3.47986362 |
41 | cytochrome complex assembly (GO:0017004) | 3.47602430 |
42 | neuron cell-cell adhesion (GO:0007158) | 3.45736246 |
43 | reverse cholesterol transport (GO:0043691) | 3.42414230 |
44 | startle response (GO:0001964) | 3.41904372 |
45 | lymphoid progenitor cell differentiation (GO:0002320) | 3.35581999 |
46 | mannosylation (GO:0097502) | 3.32760554 |
47 | neurofilament cytoskeleton organization (GO:0060052) | 3.32329132 |
48 | protein complex biogenesis (GO:0070271) | 3.32263782 |
49 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 3.28046430 |
50 | negative regulation of hematopoietic progenitor cell differentiation (GO:1901533) | 3.27973848 |
51 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.26421762 |
52 | neurotransmitter secretion (GO:0007269) | 3.26086347 |
53 | N-acetylneuraminate metabolic process (GO:0006054) | 3.25901736 |
54 | protein localization to cilium (GO:0061512) | 3.25184027 |
55 | mast cell activation (GO:0045576) | 3.24435714 |
56 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.22457361 |
57 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.19188724 |
58 | organelle membrane fusion (GO:0090174) | 3.19031523 |
59 | cellular extravasation (GO:0045123) | 3.19024162 |
60 | positive regulation of synapse assembly (GO:0051965) | 3.18562211 |
61 | regulation of regulatory T cell differentiation (GO:0045589) | 3.18083370 |
62 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.18082744 |
63 | platelet aggregation (GO:0070527) | 3.18038896 |
64 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.17821679 |
65 | adenosine receptor signaling pathway (GO:0001973) | 3.16448516 |
66 | mast cell activation involved in immune response (GO:0002279) | 3.15219697 |
67 | mast cell degranulation (GO:0043303) | 3.15219697 |
68 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.15053690 |
69 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.14195355 |
70 | positive regulation of endothelial cell differentiation (GO:0045603) | 3.13939893 |
71 | gamma-aminobutyric acid transport (GO:0015812) | 3.11854032 |
72 | activated T cell proliferation (GO:0050798) | 3.11539139 |
73 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 3.10651566 |
74 | response to histamine (GO:0034776) | 3.09172295 |
75 | negative regulation of norepinephrine secretion (GO:0010700) | 3.08608920 |
76 | behavioral response to nicotine (GO:0035095) | 3.07604581 |
77 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.07130793 |
78 | angiogenesis involved in wound healing (GO:0060055) | 3.05531174 |
79 | positive regulation of amino acid transport (GO:0051957) | 3.03701612 |
80 | negative regulation of appetite (GO:0032099) | 3.02780303 |
81 | negative regulation of response to food (GO:0032096) | 3.02780303 |
82 | purinergic receptor signaling pathway (GO:0035587) | 2.97973397 |
83 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.97795491 |
84 | protein localization to synapse (GO:0035418) | 2.97165148 |
85 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.96783151 |
86 | negative regulation of T cell apoptotic process (GO:0070233) | 2.96297877 |
87 | neurotransmitter transport (GO:0006836) | 2.94252350 |
88 | termination of G-protein coupled receptor signaling pathway (GO:0038032) | 2.93884090 |
89 | lipoxygenase pathway (GO:0019372) | 2.93485855 |
90 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.92643078 |
91 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.92199633 |
92 | regulation of mast cell activation (GO:0033003) | 2.91589960 |
93 | oxaloacetate metabolic process (GO:0006107) | 2.89957545 |
94 | synaptic transmission, glutamatergic (GO:0035249) | 2.89438466 |
95 | regulation of lipoprotein metabolic process (GO:0050746) | 2.87740401 |
96 | neuron-neuron synaptic transmission (GO:0007270) | 2.86861075 |
97 | tolerance induction (GO:0002507) | 2.86790825 |
98 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.86693824 |
99 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.86174841 |
100 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.83967012 |
101 | microglial cell activation (GO:0001774) | 2.82755910 |
102 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.82567677 |
103 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.82567677 |
104 | NADH dehydrogenase complex assembly (GO:0010257) | 2.82567677 |
105 | dopamine transport (GO:0015872) | 2.82042510 |
106 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.81534847 |
107 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.80798963 |
108 | negative regulation of type 2 immune response (GO:0002829) | 2.79687966 |
109 | termination of signal transduction (GO:0023021) | 2.79069818 |
110 | myeloid cell activation involved in immune response (GO:0002275) | 2.78787449 |
111 | regulation of female receptivity (GO:0045924) | 2.78235055 |
112 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.77089615 |
113 | positive regulation of macrophage differentiation (GO:0045651) | 2.76327562 |
114 | short-term memory (GO:0007614) | 2.76032032 |
115 | positive regulation of DNA recombination (GO:0045911) | 2.75977286 |
116 | catecholamine transport (GO:0051937) | 2.74830555 |
117 | aerobic respiration (GO:0009060) | 2.74436932 |
118 | positive regulation of mitochondrial fission (GO:0090141) | 2.72467716 |
119 | regulation of neurotransmitter levels (GO:0001505) | 2.72019129 |
120 | regulation of penile erection (GO:0060405) | 2.71841005 |
121 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.71057785 |
122 | negative regulation of cell killing (GO:0031342) | 2.71057785 |
123 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.70949820 |
124 | synaptic vesicle exocytosis (GO:0016079) | 2.70755239 |
125 | megakaryocyte development (GO:0035855) | 2.70274554 |
126 | cranial nerve morphogenesis (GO:0021602) | 2.68881705 |
127 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.67237567 |
128 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.67092608 |
129 | positive regulation of B cell mediated immunity (GO:0002714) | 2.67092608 |
130 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.66912681 |
131 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.66561732 |
132 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.66136079 |
133 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.66044009 |
134 | positive regulation of isotype switching (GO:0045830) | 2.64582949 |
135 | regulation of homotypic cell-cell adhesion (GO:0034110) | 2.64425834 |
136 | negative regulation of heart rate (GO:0010459) | 2.63870843 |
137 | acrosome reaction (GO:0007340) | 2.61519952 |
138 | regulation of thymocyte apoptotic process (GO:0070243) | 2.61518563 |
139 | proteasome assembly (GO:0043248) | 2.60729378 |
140 | cellular biogenic amine catabolic process (GO:0042402) | 2.60596691 |
141 | amine catabolic process (GO:0009310) | 2.60596691 |
142 | neurotransmitter biosynthetic process (GO:0042136) | 2.60369785 |
143 | righting reflex (GO:0060013) | 2.59639051 |
144 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.58326963 |
145 | glutamate receptor signaling pathway (GO:0007215) | 2.57175171 |
146 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.55324921 |
147 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.54689620 |
148 | mitochondrial fission (GO:0000266) | 2.54369341 |
149 | monoamine transport (GO:0015844) | 2.54195578 |
150 | platelet formation (GO:0030220) | 2.54136878 |
151 | hepatocyte apoptotic process (GO:0097284) | 2.54033066 |
152 | platelet dense granule organization (GO:0060155) | 2.53337720 |
153 | regulation of cholesterol esterification (GO:0010872) | 2.52382957 |
154 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.52296426 |
155 | superoxide anion generation (GO:0042554) | 2.52005775 |
156 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.50764078 |
157 | regulation of protein kinase A signaling (GO:0010738) | 2.50718047 |
158 | DNA deamination (GO:0045006) | 2.49914438 |
159 | neurotransmitter uptake (GO:0001504) | 2.49723492 |
160 | cellular biogenic amine biosynthetic process (GO:0042401) | 2.49226705 |
161 | regulation of synapse structural plasticity (GO:0051823) | 2.49224467 |
162 | homotypic cell-cell adhesion (GO:0034109) | 2.49083456 |
163 | positive regulation of membrane potential (GO:0045838) | 2.48998062 |
164 | respiratory electron transport chain (GO:0022904) | 2.48457423 |
165 | positive regulation of Rho protein signal transduction (GO:0035025) | 2.48317885 |
166 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.47674392 |
167 | negative regulation of B cell mediated immunity (GO:0002713) | 2.47674392 |
168 | lysosome localization (GO:0032418) | 2.47060736 |
169 | electron transport chain (GO:0022900) | 2.47051386 |
170 | ether lipid metabolic process (GO:0046485) | 2.46959401 |
171 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.46597466 |
172 | synaptic vesicle maturation (GO:0016188) | 2.46307549 |
173 | polyamine biosynthetic process (GO:0006596) | 2.45967826 |
174 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.45724704 |
175 | regulation of synapse assembly (GO:0051963) | 2.44582819 |
176 | inositol phosphate catabolic process (GO:0071545) | 2.43299325 |
177 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.43210288 |
178 | chaperone-mediated protein transport (GO:0072321) | 2.42965968 |
179 | positive regulation of action potential (GO:0045760) | 2.42054916 |
180 | fatty acid elongation (GO:0030497) | 2.41802140 |
181 | cytidine catabolic process (GO:0006216) | 2.41286292 |
182 | mature B cell differentiation involved in immune response (GO:0002313) | 2.39966132 |
183 | GDP-mannose metabolic process (GO:0019673) | 2.39768871 |
184 | positive regulation of amine transport (GO:0051954) | 2.37078684 |
185 | serotonin receptor signaling pathway (GO:0007210) | 2.37047704 |
186 | cofactor catabolic process (GO:0051187) | 2.34682650 |
187 | sympathetic nervous system development (GO:0048485) | 2.34620706 |
188 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.34286905 |
189 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.33655802 |
190 | mature B cell differentiation (GO:0002335) | 2.32011711 |
191 | negative regulation of alpha-beta T cell differentiation (GO:0046639) | 2.30385505 |
192 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.29334378 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 7.38424904 |
2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.82350215 |
3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.29530436 |
4 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.72524456 |
5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.72220366 |
6 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.70946554 |
7 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.67050518 |
8 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.60218559 |
9 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.56300767 |
10 | VDR_22108803_ChIP-Seq_LS180_Human | 2.49975203 |
11 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.47358044 |
12 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.40648750 |
13 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.24707510 |
14 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.16684403 |
15 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.09506797 |
16 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.08655554 |
17 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.04279104 |
18 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.03939450 |
19 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.02267332 |
20 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.99215769 |
21 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.98860382 |
22 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.96390142 |
23 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.96155898 |
24 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.93319082 |
25 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.93319082 |
26 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.91149568 |
27 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.86163435 |
28 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.84314305 |
29 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.82464946 |
30 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.80300211 |
31 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.75413849 |
32 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.73596150 |
33 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.72856513 |
34 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.72305815 |
35 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.71496638 |
36 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.66906276 |
37 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.63387331 |
38 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.63172216 |
39 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.60162867 |
40 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59275696 |
41 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.57053173 |
42 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.56529916 |
43 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.54961347 |
44 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.48174082 |
45 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.48043893 |
46 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.47765874 |
47 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.46772058 |
48 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.46649796 |
49 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.46245069 |
50 | GATA3_26560356_Chip-Seq_TH2_Human | 1.45147364 |
51 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.44012771 |
52 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.43768548 |
53 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.42868381 |
54 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.42498244 |
55 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.42072371 |
56 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.41046042 |
57 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.40270060 |
58 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.39867822 |
59 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.39688260 |
60 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.39599318 |
61 | EWS_26573619_Chip-Seq_HEK293_Human | 1.38889520 |
62 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.38552193 |
63 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.37738659 |
64 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.37684146 |
65 | P300_19829295_ChIP-Seq_ESCs_Human | 1.36920134 |
66 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.36617923 |
67 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.34902752 |
68 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34619651 |
69 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.34525983 |
70 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.34119290 |
71 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.33170398 |
72 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.29216029 |
73 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.26024571 |
74 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.26024571 |
75 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.25801291 |
76 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.25566121 |
77 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.24885608 |
78 | * MYB_26560356_Chip-Seq_TH2_Human | 1.24757978 |
79 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.23016645 |
80 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.22171744 |
81 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.21395688 |
82 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.21320042 |
83 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.21281533 |
84 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.20982334 |
85 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.20951959 |
86 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.20658262 |
87 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.19592315 |
88 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.18158797 |
89 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.15900894 |
90 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.15900894 |
91 | AR_25329375_ChIP-Seq_VCAP_Human | 1.14966098 |
92 | KDM2B_26808549_Chip-Seq_REH_Human | 1.14487056 |
93 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.12734051 |
94 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.12702966 |
95 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.12335142 |
96 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.11791403 |
97 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.11552679 |
98 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.10214043 |
99 | * KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.09879052 |
100 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.09848774 |
101 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.09308466 |
102 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.08835612 |
103 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.08675268 |
104 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.08197072 |
105 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.07559537 |
106 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.06764205 |
107 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.05925299 |
108 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.05196861 |
109 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.05190935 |
110 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.04621929 |
111 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.03660797 |
112 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.03237732 |
113 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.03042200 |
114 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.02962553 |
115 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.02838247 |
116 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02212801 |
117 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.01928498 |
118 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.01768456 |
119 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.00203314 |
120 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.99851871 |
121 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.99540424 |
122 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.99399434 |
123 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.98513946 |
124 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.98411609 |
125 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.97944685 |
126 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.97376171 |
127 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.96515359 |
128 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.96369065 |
129 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.95673658 |
130 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.95273869 |
131 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.95133036 |
132 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.94990469 |
133 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.94639906 |
134 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.94474863 |
135 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93813033 |
136 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.92825517 |
137 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.92776324 |
138 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.90404428 |
139 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.90212345 |
140 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.90183898 |
141 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.89692849 |
142 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.88588166 |
143 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.88408305 |
144 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.88349326 |
145 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.88111251 |
146 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.87729662 |
147 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.87729662 |
148 | JUN_21703547_ChIP-Seq_K562_Human | 0.86217637 |
149 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.84989029 |
150 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.84653001 |
151 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.81980548 |
152 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.81572273 |
153 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.81486090 |
154 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.81080482 |
155 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.80796613 |
156 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.80358002 |
157 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.79691651 |
158 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.79309205 |
159 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.79214380 |
160 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.77729680 |
161 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.76229468 |
162 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.75930705 |
163 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.75840318 |
164 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.75751357 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005464_abnormal_platelet_physiology | 6.70289548 |
2 | MP0008004_abnormal_stomach_pH | 3.78009544 |
3 | MP0003880_abnormal_central_pattern | 3.36652249 |
4 | MP0006276_abnormal_autonomic_nervous | 3.28936676 |
5 | MP0002139_abnormal_hepatobiliary_system | 3.04264855 |
6 | MP0009379_abnormal_foot_pigmentation | 3.04066490 |
7 | MP0009046_muscle_twitch | 2.83519174 |
8 | MP0001188_hyperpigmentation | 2.64044399 |
9 | MP0001986_abnormal_taste_sensitivity | 2.59663596 |
10 | MP0003879_abnormal_hair_cell | 2.51449863 |
11 | MP0001968_abnormal_touch/_nociception | 2.48073272 |
12 | MP0009745_abnormal_behavioral_response | 2.45664687 |
13 | MP0003646_muscle_fatigue | 2.42538420 |
14 | MP0003635_abnormal_synaptic_transmissio | 2.42228342 |
15 | MP0002735_abnormal_chemical_nociception | 2.41713411 |
16 | MP0002064_seizures | 2.18803359 |
17 | MP0002876_abnormal_thyroid_physiology | 2.18044200 |
18 | MP0002272_abnormal_nervous_system | 2.15653964 |
19 | MP0005084_abnormal_gallbladder_morpholo | 2.14110623 |
20 | MP0003303_peritoneal_inflammation | 2.14109426 |
21 | MP0004859_abnormal_synaptic_plasticity | 2.13938104 |
22 | MP0000372_irregular_coat_pigmentation | 2.08570300 |
23 | MP0004142_abnormal_muscle_tone | 2.02330386 |
24 | MP0000015_abnormal_ear_pigmentation | 1.97990986 |
25 | MP0002736_abnormal_nociception_after | 1.92524311 |
26 | MP0003868_abnormal_feces_composition | 1.91683408 |
27 | MP0005083_abnormal_biliary_tract | 1.84882309 |
28 | MP0001501_abnormal_sleep_pattern | 1.81615948 |
29 | MP0003122_maternal_imprinting | 1.79902016 |
30 | MP0002067_abnormal_sensory_capabilities | 1.77687440 |
31 | MP0002572_abnormal_emotion/affect_behav | 1.75920879 |
32 | MP0005409_darkened_coat_color | 1.74699927 |
33 | MP0000569_abnormal_digit_pigmentation | 1.72127861 |
34 | MP0004381_abnormal_hair_follicle | 1.71495019 |
35 | MP0005174_abnormal_tail_pigmentation | 1.65425146 |
36 | MP0005000_abnormal_immune_tolerance | 1.63330967 |
37 | MP0002734_abnormal_mechanical_nocicepti | 1.58727282 |
38 | MP0010386_abnormal_urinary_bladder | 1.54581633 |
39 | MP0000230_abnormal_systemic_arterial | 1.54140308 |
40 | MP0001970_abnormal_pain_threshold | 1.53792428 |
41 | MP0005167_abnormal_blood-brain_barrier | 1.52747765 |
42 | MP0003763_abnormal_thymus_physiology | 1.51144542 |
43 | MP0002733_abnormal_thermal_nociception | 1.50581671 |
44 | MP0002723_abnormal_immune_serum | 1.50564545 |
45 | MP0010329_abnormal_lipoprotein_level | 1.50062983 |
46 | MP0002909_abnormal_adrenal_gland | 1.49473324 |
47 | MP0002063_abnormal_learning/memory/cond | 1.49143566 |
48 | MP0002822_catalepsy | 1.48519024 |
49 | MP0003724_increased_susceptibility_to | 1.46481861 |
50 | MP0002398_abnormal_bone_marrow | 1.46161032 |
51 | MP0005645_abnormal_hypothalamus_physiol | 1.44593513 |
52 | MP0004270_analgesia | 1.44197813 |
53 | MP0002184_abnormal_innervation | 1.44144130 |
54 | MP0001835_abnormal_antigen_presentation | 1.43453005 |
55 | MP0001486_abnormal_startle_reflex | 1.41905142 |
56 | MP0002095_abnormal_skin_pigmentation | 1.40830099 |
57 | MP0002557_abnormal_social/conspecific_i | 1.40635791 |
58 | MP0008569_lethality_at_weaning | 1.40570384 |
59 | MP0002420_abnormal_adaptive_immunity | 1.39510535 |
60 | MP0003787_abnormal_imprinting | 1.38954658 |
61 | MP0002132_abnormal_respiratory_system | 1.38917035 |
62 | MP0000681_abnormal_thyroid_gland | 1.38869965 |
63 | MP0003191_abnormal_cellular_cholesterol | 1.37421352 |
64 | MP0008877_abnormal_DNA_methylation | 1.37386470 |
65 | MP0001819_abnormal_immune_cell | 1.36402517 |
66 | MP0003436_decreased_susceptibility_to | 1.35024246 |
67 | MP0002452_abnormal_antigen_presenting | 1.33172548 |
68 | MP0002638_abnormal_pupillary_reflex | 1.29847684 |
69 | MP0000689_abnormal_spleen_morphology | 1.29494315 |
70 | MP0000465_gastrointestinal_hemorrhage | 1.29051580 |
71 | MP0002653_abnormal_ependyma_morphology | 1.28000728 |
72 | MP0003828_pulmonary_edema | 1.26160363 |
73 | MP0004510_myositis | 1.25827602 |
74 | MP0005646_abnormal_pituitary_gland | 1.24755722 |
75 | MP0005671_abnormal_response_to | 1.24432238 |
76 | MP0002138_abnormal_hepatobiliary_system | 1.22378791 |
77 | MP0002419_abnormal_innate_immunity | 1.22295927 |
78 | MP0005410_abnormal_fertilization | 1.22071971 |
79 | MP0005423_abnormal_somatic_nervous | 1.20430401 |
80 | MP0002102_abnormal_ear_morphology | 1.20325279 |
81 | MP0010155_abnormal_intestine_physiology | 1.19481231 |
82 | MP0001851_eye_inflammation | 1.19242568 |
83 | MP0009333_abnormal_splenocyte_physiolog | 1.18070287 |
84 | MP0008775_abnormal_heart_ventricle | 1.17825686 |
85 | MP0001905_abnormal_dopamine_level | 1.17275989 |
86 | MP0005075_abnormal_melanosome_morpholog | 1.15507796 |
87 | MP0003638_abnormal_response/metabolism_ | 1.15167017 |
88 | MP0001440_abnormal_grooming_behavior | 1.15093843 |
89 | MP0000716_abnormal_immune_system | 1.14981600 |
90 | MP0009764_decreased_sensitivity_to | 1.13620400 |
91 | MP0002277_abnormal_respiratory_mucosa | 1.13619313 |
92 | MP0003195_calcinosis | 1.12260523 |
93 | MP0004147_increased_porphyrin_level | 1.12215392 |
94 | MP0004484_altered_response_of | 1.11655378 |
95 | MP0009785_altered_susceptibility_to | 1.11051630 |
96 | MP0002722_abnormal_immune_system | 1.10970540 |
97 | MP0001879_abnormal_lymphatic_vessel | 1.07858181 |
98 | MP0002429_abnormal_blood_cell | 1.06329180 |
99 | MP0008874_decreased_physiological_sensi | 1.05517271 |
100 | MP0000343_altered_response_to | 1.04824241 |
101 | MP0008875_abnormal_xenobiotic_pharmacok | 1.04736567 |
102 | MP0000703_abnormal_thymus_morphology | 1.01812452 |
103 | MP0001529_abnormal_vocalization | 1.01363307 |
104 | MP0005551_abnormal_eye_electrophysiolog | 1.00898204 |
105 | MP0004924_abnormal_behavior | 1.00337794 |
106 | MP0005386_behavior/neurological_phenoty | 1.00337794 |
107 | MP0001845_abnormal_inflammatory_respons | 0.99722489 |
108 | MP0002405_respiratory_system_inflammati | 0.99013843 |
109 | MP0001348_abnormal_lacrimal_gland | 0.96451219 |
110 | MP0001545_abnormal_hematopoietic_system | 0.96395493 |
111 | MP0005365_abnormal_bile_salt | 0.96177442 |
112 | MP0000604_amyloidosis | 0.94912845 |
113 | MP0003011_delayed_dark_adaptation | 0.94085272 |
114 | MP0001533_abnormal_skeleton_physiology | 0.93286154 |
115 | MP0000685_abnormal_immune_system | 0.93152335 |
116 | MP0005310_abnormal_salivary_gland | 0.92220866 |
117 | MP0006036_abnormal_mitochondrial_physio | 0.91889231 |
118 | MP0006054_spinal_hemorrhage | 0.90813156 |
119 | MP0000751_myopathy | 0.89251943 |
120 | MP0003329_amyloid_beta_deposits | 0.89244716 |
121 | MP0004215_abnormal_myocardial_fiber | 0.88758721 |
122 | MP0003656_abnormal_erythrocyte_physiolo | 0.88258477 |
123 | MP0001873_stomach_inflammation | 0.87495898 |
124 | MP0006035_abnormal_mitochondrial_morpho | 0.87449672 |
125 | MP0009765_abnormal_xenobiotic_induced | 0.86868747 |
126 | MP0004130_abnormal_muscle_cell | 0.86202346 |
127 | MP0005085_abnormal_gallbladder_physiolo | 0.85933396 |
128 | MP0001663_abnormal_digestive_system | 0.85033321 |
129 | MP0009763_increased_sensitivity_to | 0.84769496 |
130 | MP0005360_urolithiasis | 0.84767614 |
131 | MP0009697_abnormal_copulation | 0.83890426 |
132 | MP0004811_abnormal_neuron_physiology | 0.82141147 |
133 | MP0008260_abnormal_autophagy | 0.80233014 |
134 | MP0009642_abnormal_blood_homeostasis | 0.78788797 |
135 | MP0003890_abnormal_embryonic-extraembry | 0.78729971 |
136 | MP0003806_abnormal_nucleotide_metabolis | 0.78163817 |
137 | MP0002396_abnormal_hematopoietic_system | 0.77173711 |
138 | MP0002066_abnormal_motor_capabilities/c | 0.77091139 |
139 | MP0005535_abnormal_body_temperature | 0.76716089 |
140 | MP0006292_abnormal_olfactory_placode | 0.75158953 |
141 | MP0005025_abnormal_response_to | 0.74648668 |
142 | MP0000249_abnormal_blood_vessel | 0.74204185 |
143 | MP0002177_abnormal_outer_ear | 0.73315776 |
144 | MP0004883_abnormal_blood_vessel | 0.73075049 |
145 | MP0002751_abnormal_autonomic_nervous | 0.72401061 |
146 | MP0008872_abnormal_physiological_respon | 0.72183187 |
147 | MP0003136_yellow_coat_color | 0.71308983 |
148 | MP0002229_neurodegeneration | 0.71063249 |
149 | MP0005595_abnormal_vascular_smooth | 0.70541327 |
150 | MP0002118_abnormal_lipid_homeostasis | 0.69787718 |
151 | MP0001963_abnormal_hearing_physiology | 0.68993025 |
152 | MP0001800_abnormal_humoral_immune | 0.68981706 |
153 | MP0004085_abnormal_heartbeat | 0.68635770 |
154 | MP0003866_abnormal_defecation | 0.68164408 |
155 | MP0002148_abnormal_hypersensitivity_rea | 0.67860153 |
156 | MP0005647_abnormal_sex_gland | 0.67805246 |
157 | MP0005387_immune_system_phenotype | 0.66964263 |
158 | MP0001790_abnormal_immune_system | 0.66964263 |
159 | MP0001984_abnormal_olfaction | 0.66114147 |
160 | MP0005397_hematopoietic_system_phenotyp | 0.65166444 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Menorrhagia (HP:0000132) | 7.10627549 |
2 | Increased mean platelet volume (HP:0011877) | 6.90139666 |
3 | Petechiae (HP:0000967) | 6.79001247 |
4 | Abnormal platelet volume (HP:0011876) | 6.78482509 |
5 | Epistaxis (HP:0000421) | 5.85944956 |
6 | Focal motor seizures (HP:0011153) | 5.67109508 |
7 | Purpura (HP:0000979) | 5.63902798 |
8 | Gingival bleeding (HP:0000225) | 5.37271205 |
9 | Hypothermia (HP:0002045) | 5.18258891 |
10 | Hyperlipoproteinemia (HP:0010980) | 4.74887835 |
11 | Reduced antithrombin III activity (HP:0001976) | 4.49018911 |
12 | Stomatitis (HP:0010280) | 4.19871753 |
13 | Type I transferrin isoform profile (HP:0003642) | 4.18991711 |
14 | Febrile seizures (HP:0002373) | 4.01482399 |
15 | Spontaneous hematomas (HP:0007420) | 3.85351968 |
16 | Impaired platelet aggregation (HP:0003540) | 3.72610922 |
17 | Abnormal platelet function (HP:0011869) | 3.72610922 |
18 | Atonic seizures (HP:0010819) | 3.67157757 |
19 | Hepatocellular necrosis (HP:0001404) | 3.53300596 |
20 | Progressive inability to walk (HP:0002505) | 3.44273248 |
21 | Dyschromatopsia (HP:0007641) | 3.43710325 |
22 | Nonprogressive disorder (HP:0003680) | 3.42423164 |
23 | Poor suck (HP:0002033) | 3.32774561 |
24 | Poikilocytosis (HP:0004447) | 3.29068238 |
25 | Acanthocytosis (HP:0001927) | 3.28922524 |
26 | Hyperventilation (HP:0002883) | 3.16585460 |
27 | Abnormal protein glycosylation (HP:0012346) | 3.08850719 |
28 | Abnormal glycosylation (HP:0012345) | 3.08850719 |
29 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.08850719 |
30 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.08850719 |
31 | Thyroid-stimulating hormone excess (HP:0002925) | 3.02256251 |
32 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.97848068 |
33 | Mitochondrial inheritance (HP:0001427) | 2.96879412 |
34 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.96849135 |
35 | Decreased central vision (HP:0007663) | 2.95839047 |
36 | Severe visual impairment (HP:0001141) | 2.90646665 |
37 | Myokymia (HP:0002411) | 2.87831749 |
38 | Prolonged partial thromboplastin time (HP:0003645) | 2.81593606 |
39 | Focal seizures (HP:0007359) | 2.78778625 |
40 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.77897608 |
41 | Abnormality of alanine metabolism (HP:0010916) | 2.77897608 |
42 | Hyperalaninemia (HP:0003348) | 2.77897608 |
43 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.77742041 |
44 | Hepatic necrosis (HP:0002605) | 2.75971147 |
45 | Increased hepatocellular lipid droplets (HP:0006565) | 2.71631882 |
46 | Abnormal pupillary function (HP:0007686) | 2.69916998 |
47 | Acute necrotizing encephalopathy (HP:0006965) | 2.67773545 |
48 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.67299322 |
49 | Prolonged bleeding time (HP:0003010) | 2.66287164 |
50 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.61231319 |
51 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.61231319 |
52 | Inability to walk (HP:0002540) | 2.61136419 |
53 | 3-Methylglutaconic aciduria (HP:0003535) | 2.60894145 |
54 | Cortical visual impairment (HP:0100704) | 2.58482167 |
55 | Increased CSF lactate (HP:0002490) | 2.57622543 |
56 | Episodic fever (HP:0001954) | 2.57018610 |
57 | Type 2 muscle fiber atrophy (HP:0003554) | 2.55098202 |
58 | Polyphagia (HP:0002591) | 2.53921868 |
59 | Paralysis (HP:0003470) | 2.53492532 |
60 | Conjunctival telangiectasia (HP:0000524) | 2.52915258 |
61 | Abnormal hair whorl (HP:0010721) | 2.52429521 |
62 | Blue irides (HP:0000635) | 2.51820360 |
63 | Oligomenorrhea (HP:0000876) | 2.51750450 |
64 | Ragged-red muscle fibers (HP:0003200) | 2.51148183 |
65 | Abnormality of the common coagulation pathway (HP:0010990) | 2.49301856 |
66 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.48574781 |
67 | Absence seizures (HP:0002121) | 2.48531531 |
68 | Lipid accumulation in hepatocytes (HP:0006561) | 2.44637685 |
69 | Increased intramyocellular lipid droplets (HP:0012240) | 2.43266526 |
70 | Tinnitus (HP:0000360) | 2.41324690 |
71 | Panhypogammaglobulinemia (HP:0003139) | 2.40327588 |
72 | Abnormality of macrophages (HP:0004311) | 2.39480141 |
73 | Renal Fanconi syndrome (HP:0001994) | 2.38998435 |
74 | Dialeptic seizures (HP:0011146) | 2.31080961 |
75 | Encephalitis (HP:0002383) | 2.28495247 |
76 | Spontaneous abortion (HP:0005268) | 2.28178694 |
77 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.24907815 |
78 | Agitation (HP:0000713) | 2.23333796 |
79 | Type II lissencephaly (HP:0007260) | 2.23313129 |
80 | Retinal dysplasia (HP:0007973) | 2.22827512 |
81 | Bruising susceptibility (HP:0000978) | 2.22672154 |
82 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.20740424 |
83 | Abnormal number of erythroid precursors (HP:0012131) | 2.20206587 |
84 | Progressive macrocephaly (HP:0004481) | 2.14790526 |
85 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.14371470 |
86 | Increased density of long bones (HP:0006392) | 2.13538498 |
87 | Muscle fiber atrophy (HP:0100295) | 2.13512828 |
88 | Meningitis (HP:0001287) | 2.13405918 |
89 | Abnormal eating behavior (HP:0100738) | 2.13060806 |
90 | Visual hallucinations (HP:0002367) | 2.12720119 |
91 | Horizontal nystagmus (HP:0000666) | 2.11960722 |
92 | Gaze-evoked nystagmus (HP:0000640) | 2.11784627 |
93 | Esotropia (HP:0000565) | 2.09846146 |
94 | Eczematoid dermatitis (HP:0000976) | 2.07538632 |
95 | Decreased muscle mass (HP:0003199) | 2.07053867 |
96 | Hypochromic microcytic anemia (HP:0004840) | 2.06150415 |
97 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.05959442 |
98 | Acute encephalopathy (HP:0006846) | 2.04873583 |
99 | Anxiety (HP:0000739) | 2.04804165 |
100 | Abolished electroretinogram (ERG) (HP:0000550) | 2.04318027 |
101 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.04132461 |
102 | Increased muscle lipid content (HP:0009058) | 2.03726487 |
103 | Progressive cerebellar ataxia (HP:0002073) | 2.01269913 |
104 | Optic disc pallor (HP:0000543) | 2.01035652 |
105 | Obstructive lung disease (HP:0006536) | 2.00344202 |
106 | Chronic obstructive pulmonary disease (HP:0006510) | 2.00344202 |
107 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.00143544 |
108 | Absent/shortened dynein arms (HP:0200106) | 2.00143544 |
109 | Generalized tonic-clonic seizures (HP:0002069) | 1.99158624 |
110 | Retinal atrophy (HP:0001105) | 1.98156779 |
111 | Exertional dyspnea (HP:0002875) | 1.98117224 |
112 | Eosinophilia (HP:0001880) | 1.97130727 |
113 | Depression (HP:0000716) | 1.96966959 |
114 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.96601985 |
115 | Lactic acidosis (HP:0003128) | 1.96066294 |
116 | Abnormality of lateral ventricle (HP:0030047) | 1.95939361 |
117 | Dysautonomia (HP:0002459) | 1.94164736 |
118 | Increased IgM level (HP:0003496) | 1.93953893 |
119 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.93637897 |
120 | Agammaglobulinemia (HP:0004432) | 1.93121429 |
121 | Hypoplasia of the fovea (HP:0007750) | 1.92970026 |
122 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.92970026 |
123 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.91127050 |
124 | Leukocytosis (HP:0001974) | 1.90666970 |
125 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.89462777 |
126 | Cerebral edema (HP:0002181) | 1.89460049 |
127 | Abnormality of the renal cortex (HP:0011035) | 1.88919222 |
128 | Pancreatic cysts (HP:0001737) | 1.88757483 |
129 | Epileptic encephalopathy (HP:0200134) | 1.87180752 |
130 | Abnormal ciliary motility (HP:0012262) | 1.86176175 |
131 | Abnormality of eosinophils (HP:0001879) | 1.85414565 |
132 | Molar tooth sign on MRI (HP:0002419) | 1.85067445 |
133 | Abnormality of midbrain morphology (HP:0002418) | 1.85067445 |
134 | Bradycardia (HP:0001662) | 1.84907028 |
135 | Absent speech (HP:0001344) | 1.83750418 |
136 | Joint hemorrhage (HP:0005261) | 1.83689955 |
137 | Infertility (HP:0000789) | 1.82943097 |
138 | Limb dystonia (HP:0002451) | 1.82304646 |
139 | Abnormality of iron homeostasis (HP:0011031) | 1.81309410 |
140 | Recurrent abscess formation (HP:0002722) | 1.80954683 |
141 | Attenuation of retinal blood vessels (HP:0007843) | 1.80920522 |
142 | Thoracic kyphosis (HP:0002942) | 1.80856472 |
143 | Abnormal auditory evoked potentials (HP:0006958) | 1.80652811 |
144 | Epidermoid cyst (HP:0200040) | 1.80279783 |
145 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.80100417 |
146 | Recurrent cutaneous fungal infections (HP:0011370) | 1.80100417 |
147 | Status epilepticus (HP:0002133) | 1.79476854 |
148 | Flat occiput (HP:0005469) | 1.79349354 |
149 | Abnormality of the prostate (HP:0008775) | 1.79279366 |
150 | Renal cortical cysts (HP:0000803) | 1.79086111 |
151 | Chest pain (HP:0100749) | 1.78717830 |
152 | IgG deficiency (HP:0004315) | 1.78565429 |
153 | Medial flaring of the eyebrow (HP:0010747) | 1.78137398 |
154 | Protruding tongue (HP:0010808) | 1.75244155 |
155 | Hypomagnesemia (HP:0002917) | 1.75216223 |
156 | Action tremor (HP:0002345) | 1.75164828 |
157 | Granulocytopenia (HP:0001913) | 1.74320371 |
158 | Truncal ataxia (HP:0002078) | 1.73653988 |
159 | Autoimmune hemolytic anemia (HP:0001890) | 1.72834459 |
160 | * Joint swelling (HP:0001386) | 1.72560158 |
161 | Congenital stationary night blindness (HP:0007642) | 1.71903296 |
162 | Hypophosphatemic rickets (HP:0004912) | 1.71280144 |
163 | Increased serum lactate (HP:0002151) | 1.71260111 |
164 | Microcytic anemia (HP:0001935) | 1.71106383 |
165 | Gait imbalance (HP:0002141) | 1.70414685 |
166 | Nephrogenic diabetes insipidus (HP:0009806) | 1.69395219 |
167 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.67662570 |
168 | Generalized aminoaciduria (HP:0002909) | 1.67059111 |
169 | Abnormality of T cell number (HP:0011839) | 1.66018627 |
170 | T lymphocytopenia (HP:0005403) | 1.64882046 |
171 | Abnormality of the fovea (HP:0000493) | 1.64566842 |
172 | Recurrent bacterial skin infections (HP:0005406) | 1.62613741 |
173 | Optic neuritis (HP:0100653) | 1.61386772 |
174 | Retrobulbar optic neuritis (HP:0100654) | 1.61386772 |
175 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.58252105 |
176 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.58252105 |
177 | Arterial thrombosis (HP:0004420) | 1.58186041 |
178 | Hepatosplenomegaly (HP:0001433) | 1.57517759 |
179 | Papillary thyroid carcinoma (HP:0002895) | 1.54574851 |
180 | Arthropathy (HP:0003040) | 1.52391922 |
181 | Ventricular fibrillation (HP:0001663) | 1.51738757 |
182 | Failure to thrive in infancy (HP:0001531) | 1.50470755 |
183 | Thrombophlebitis (HP:0004418) | 1.50122956 |
184 | Cerebral hemorrhage (HP:0001342) | 1.49462963 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MUSK | 5.36349730 |
2 | TNIK | 5.24505363 |
3 | MST4 | 3.99279699 |
4 | CAMKK2 | 3.80597773 |
5 | MAP2K7 | 3.67682300 |
6 | MAP3K12 | 3.64144888 |
7 | NTRK3 | 3.52462099 |
8 | CASK | 3.21435524 |
9 | FRK | 2.75385381 |
10 | TRIM28 | 2.63995652 |
11 | ACVR1B | 2.50582497 |
12 | PTK2B | 2.29401872 |
13 | FES | 2.27299574 |
14 | BMPR1B | 2.21235443 |
15 | BMX | 2.15206290 |
16 | KIT | 2.14064862 |
17 | MAP3K4 | 1.91113037 |
18 | GRK6 | 1.89744596 |
19 | NUAK1 | 1.88782749 |
20 | NME2 | 1.88651767 |
21 | ZAP70 | 1.70331673 |
22 | CAMKK1 | 1.63247846 |
23 | CAMK1 | 1.61070701 |
24 | MAP2K4 | 1.58722951 |
25 | CSNK1G3 | 1.54994046 |
26 | ADRBK2 | 1.54159120 |
27 | NLK | 1.52816535 |
28 | GRK7 | 1.51939909 |
29 | CAMK1G | 1.50760790 |
30 | CDK19 | 1.50570074 |
31 | ITK | 1.43492816 |
32 | PINK1 | 1.39633380 |
33 | CAMK1D | 1.39186198 |
34 | EIF2AK1 | 1.36991545 |
35 | TEC | 1.36750492 |
36 | IRAK3 | 1.30454112 |
37 | STK16 | 1.30355313 |
38 | GRK1 | 1.29733440 |
39 | CSNK1G2 | 1.29140263 |
40 | CSNK1G1 | 1.20268881 |
41 | MAP2K3 | 1.19584888 |
42 | MAPK13 | 1.17866477 |
43 | MINK1 | 1.17437239 |
44 | NTRK2 | 1.13648843 |
45 | CSK | 1.10661390 |
46 | CSNK1A1L | 1.07077602 |
47 | FGR | 1.06779331 |
48 | PLK2 | 1.06350490 |
49 | MATK | 1.05752754 |
50 | DAPK2 | 1.05386824 |
51 | STK3 | 1.02465813 |
52 | MAP3K5 | 1.01225347 |
53 | TBK1 | 1.00694148 |
54 | EIF2AK3 | 0.98720620 |
55 | YES1 | 0.96706372 |
56 | PIM2 | 0.95929840 |
57 | MAP4K2 | 0.94477901 |
58 | MARK1 | 0.93157385 |
59 | ERBB4 | 0.91059553 |
60 | MARK3 | 0.90983042 |
61 | BLK | 0.88935814 |
62 | TIE1 | 0.88329449 |
63 | PAK3 | 0.87685152 |
64 | SYK | 0.85467536 |
65 | PDK4 | 0.85286846 |
66 | PDK3 | 0.85286846 |
67 | NTRK1 | 0.84360489 |
68 | TAOK3 | 0.83143223 |
69 | MAPK4 | 0.80193881 |
70 | IRAK2 | 0.78920913 |
71 | IRAK4 | 0.78030239 |
72 | ARAF | 0.76896247 |
73 | MAP3K1 | 0.76871710 |
74 | ICK | 0.74959742 |
75 | PRKCQ | 0.74825196 |
76 | CAMK4 | 0.74130812 |
77 | BMPR2 | 0.73695523 |
78 | GRK5 | 0.73053080 |
79 | MKNK2 | 0.72831997 |
80 | MAP3K11 | 0.71733300 |
81 | MYLK | 0.70103053 |
82 | BTK | 0.69928642 |
83 | PRKCG | 0.69458192 |
84 | IKBKE | 0.68352942 |
85 | PRKG2 | 0.68030503 |
86 | TAOK2 | 0.67317746 |
87 | UHMK1 | 0.66037782 |
88 | TXK | 0.65224960 |
89 | TNK2 | 0.65154790 |
90 | MAP3K9 | 0.63213894 |
91 | FER | 0.61204370 |
92 | TLK1 | 0.60840137 |
93 | PRPF4B | 0.60056405 |
94 | CSF1R | 0.59421423 |
95 | OXSR1 | 0.56316749 |
96 | PDK2 | 0.55749728 |
97 | CAMK2G | 0.55172386 |
98 | IRAK1 | 0.53045300 |
99 | ZAK | 0.51381710 |
100 | ERBB2 | 0.51087482 |
101 | HIPK2 | 0.50990602 |
102 | TYK2 | 0.50792564 |
103 | MAPKAPK3 | 0.50086614 |
104 | CAMK2A | 0.49922196 |
105 | STK4 | 0.49750449 |
106 | PNCK | 0.49545093 |
107 | ADRBK1 | 0.49445163 |
108 | PDK1 | 0.49015359 |
109 | JAK1 | 0.48491071 |
110 | JAK2 | 0.48225514 |
111 | ILK | 0.46895820 |
112 | SGK2 | 0.46611219 |
113 | TAOK1 | 0.45810071 |
114 | PAK1 | 0.45572166 |
115 | CDK8 | 0.44385015 |
116 | DAPK3 | 0.43604183 |
117 | WNK4 | 0.43466352 |
118 | WNK3 | 0.43405267 |
119 | RIPK4 | 0.42861101 |
120 | IKBKB | 0.42697628 |
121 | SIK3 | 0.42588776 |
122 | DYRK2 | 0.41721353 |
123 | CDK3 | 0.39974861 |
124 | BCR | 0.39366104 |
125 | SIK2 | 0.39356504 |
126 | PRKG1 | 0.38915256 |
127 | EPHB1 | 0.37870717 |
128 | JAK3 | 0.37277061 |
129 | INSRR | 0.37180981 |
130 | CDK5 | 0.36912164 |
131 | PRKACA | 0.35941362 |
132 | PIK3CG | 0.35647129 |
133 | PRKCE | 0.35157883 |
134 | DAPK1 | 0.34937138 |
135 | PRKD1 | 0.34634700 |
136 | MAPK12 | 0.34612591 |
137 | MAP4K1 | 0.34149094 |
138 | MAP2K6 | 0.33780528 |
139 | LYN | 0.33705601 |
140 | FLT3 | 0.33496993 |
141 | STK38 | 0.32207951 |
142 | LCK | 0.31935399 |
143 | EPHA3 | 0.31504743 |
144 | BCKDK | 0.31250981 |
145 | PDGFRB | 0.30675029 |
146 | RET | 0.29987555 |
147 | RPS6KB1 | 0.28461389 |
148 | MAPKAPK5 | 0.26534704 |
149 | PHKG1 | 0.26348552 |
150 | PHKG2 | 0.26348552 |
151 | HCK | 0.25497709 |
152 | CAMK2B | 0.25293580 |
153 | PRKACG | 0.24489226 |
154 | PIM1 | 0.24095026 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Platelet activation_Homo sapiens_hsa04611 | 4.20655283 |
2 | Nicotine addiction_Homo sapiens_hsa05033 | 4.18902140 |
3 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.36443143 |
4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.13617697 |
5 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.86528152 |
6 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.83085373 |
7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.81275389 |
8 | Parkinsons disease_Homo sapiens_hsa05012 | 2.46473785 |
9 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 2.37483331 |
10 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.25880488 |
11 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.15375940 |
12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.11403161 |
13 | Taste transduction_Homo sapiens_hsa04742 | 2.09061372 |
14 | Alzheimers disease_Homo sapiens_hsa05010 | 2.04822721 |
15 | GABAergic synapse_Homo sapiens_hsa04727 | 1.96519918 |
16 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.93029429 |
17 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.89138937 |
18 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.85435284 |
19 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.84069992 |
20 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.75813428 |
21 | Huntingtons disease_Homo sapiens_hsa05016 | 1.72848643 |
22 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.70631547 |
23 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.67024269 |
24 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.65500851 |
25 | Ribosome_Homo sapiens_hsa03010 | 1.57814547 |
26 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.55883069 |
27 | Olfactory transduction_Homo sapiens_hsa04740 | 1.52114370 |
28 | Protein export_Homo sapiens_hsa03060 | 1.51339085 |
29 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.47528154 |
30 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.45596626 |
31 | Morphine addiction_Homo sapiens_hsa05032 | 1.44059638 |
32 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.42976169 |
33 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.42591598 |
34 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.39990917 |
35 | Circadian entrainment_Homo sapiens_hsa04713 | 1.33410714 |
36 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.32026458 |
37 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.31771672 |
38 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.29256941 |
39 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.28749271 |
40 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.27295849 |
41 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.20092865 |
42 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.18909030 |
43 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.17889574 |
44 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.17568268 |
45 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.17500246 |
46 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.17168321 |
47 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.17155341 |
48 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.16947245 |
49 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.15848389 |
50 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.13795830 |
51 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.11349794 |
52 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.10429200 |
53 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.07696829 |
54 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.07019595 |
55 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.06469286 |
56 | Sulfur relay system_Homo sapiens_hsa04122 | 1.04031972 |
57 | Phagosome_Homo sapiens_hsa04145 | 1.01937989 |
58 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.01605204 |
59 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.00585169 |
60 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.00166193 |
61 | Basal transcription factors_Homo sapiens_hsa03022 | 0.99570701 |
62 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.98781584 |
63 | Cocaine addiction_Homo sapiens_hsa05030 | 0.96750716 |
64 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.96429616 |
65 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.94113256 |
66 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.93490269 |
67 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.93244509 |
68 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.92864270 |
69 | Salivary secretion_Homo sapiens_hsa04970 | 0.91131763 |
70 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.89941177 |
71 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.88606963 |
72 | Endocytosis_Homo sapiens_hsa04144 | 0.88550500 |
73 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.86747591 |
74 | Insulin secretion_Homo sapiens_hsa04911 | 0.86413480 |
75 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.85814635 |
76 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.84962917 |
77 | Allograft rejection_Homo sapiens_hsa05330 | 0.84891210 |
78 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.83454607 |
79 | Long-term depression_Homo sapiens_hsa04730 | 0.81142707 |
80 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.80919892 |
81 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.80609036 |
82 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.80522520 |
83 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.78886992 |
84 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.78660314 |
85 | Long-term potentiation_Homo sapiens_hsa04720 | 0.76363942 |
86 | Measles_Homo sapiens_hsa05162 | 0.75785973 |
87 | ABC transporters_Homo sapiens_hsa02010 | 0.74350726 |
88 | Proteasome_Homo sapiens_hsa03050 | 0.74179861 |
89 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.71452937 |
90 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.70883311 |
91 | Phototransduction_Homo sapiens_hsa04744 | 0.69198696 |
92 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.68891107 |
93 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.64911766 |
94 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.64730396 |
95 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.63533675 |
96 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.62901447 |
97 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.62575835 |
98 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.59832566 |
99 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.59209867 |
100 | Retinol metabolism_Homo sapiens_hsa00830 | 0.58527772 |
101 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.58052918 |
102 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.57935659 |
103 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.57622557 |
104 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.56583071 |
105 | Metabolic pathways_Homo sapiens_hsa01100 | 0.56527926 |
106 | Shigellosis_Homo sapiens_hsa05131 | 0.56501473 |
107 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.56362649 |
108 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.56215510 |
109 | Other glycan degradation_Homo sapiens_hsa00511 | 0.55103415 |
110 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.53885802 |
111 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.53826361 |
112 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.52922766 |
113 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.52191346 |
114 | Malaria_Homo sapiens_hsa05144 | 0.51894343 |
115 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.51847741 |
116 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.50980617 |
117 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.50659202 |
118 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.49462337 |
119 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.48654092 |
120 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.47763968 |
121 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.47558577 |
122 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.47434054 |
123 | Renin secretion_Homo sapiens_hsa04924 | 0.47114736 |
124 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.45137209 |
125 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.44500393 |
126 | Histidine metabolism_Homo sapiens_hsa00340 | 0.43998478 |
127 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.43500856 |
128 | Legionellosis_Homo sapiens_hsa05134 | 0.41857307 |
129 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.41738805 |
130 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.41297153 |
131 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.41240084 |
132 | Tuberculosis_Homo sapiens_hsa05152 | 0.41224289 |
133 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.41131132 |
134 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.40591015 |
135 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.40463596 |
136 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.40453700 |
137 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.39974138 |
138 | Alcoholism_Homo sapiens_hsa05034 | 0.38964090 |
139 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.36026699 |
140 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.36019295 |
141 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.35577398 |
142 | Asthma_Homo sapiens_hsa05310 | 0.34643689 |
143 | Peroxisome_Homo sapiens_hsa04146 | 0.33355711 |
144 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.32418132 |
145 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.31442819 |
146 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.31070308 |
147 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.30545085 |
148 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.30251813 |
149 | Thyroid cancer_Homo sapiens_hsa05216 | 0.30004462 |
150 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.29998946 |
151 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.28406660 |
152 | Gap junction_Homo sapiens_hsa04540 | 0.27982953 |
153 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.27947327 |